Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Saksela

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|December 22, 2010
[Dysplastic melanocytic nevus]Alexander Salava, Annamari Ranki, Olli Saksela
Acta Dermato-Venereologica|June 21, 2003
Multinucleate cell angiohistiocytoma: a report of four cases in FinlandLiisa Väkevä, Olli Saksela, Arja-Leena Kariniemi
Acta Dermato-Venereologica|October 8, 2013
Melanoma on tattoos: two Finnish casesNicolas Kluger, Sari Koskenmies, Leila Jeskanen, et al.
Experimental Dermatology|March 3, 2005
FGF-2 blocks TGF-beta1-mediated suppression of Bcl-2 in normal melanocytesMaria von Willebrand, Klaus Köhler, Tuomo Alanko, et al.
The American Journal of Pathology|October 16, 2012
TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cellsMiao Yin, Johanna Soikkeli, Tiina Jahkola, et al.
Duodecim; Laaketieteellinen Aikakauskirja|August 5, 2015
[Diagnosis and treatment of actinic keratosis]Kirsi Isoherranen, Sari Koskenmies, Meri Overmark, et al.
The American Journal of Pathology|January 14, 2014
Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9Miao Yin, Johanna Soikkeli, Tiina Jahkola, et al.
The American Journal of Pathology|February 14, 2012
Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cellsPirjo Nummela, Johanna Lammi, Johanna Soikkeli, et al.
Molecular Oncology|February 14, 2020
Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel wallsJohanna Eriksson, Vadim Le Joncour, Tiina Jahkola, et al.
Virchows Archiv : an International Journal of Pathology|September 1, 2005
MMP-21 is upregulated at early stages of melanoma progression but disappears with more aggressive phenotypeTiina Kuivanen, Katja Ahokas, Susanna Virolainen, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Duodecim; Laaketieteellinen Aikakauskirja|December 22, 2010
[Dysplastic melanocytic nevus]Alexander Salava, Annamari Ranki, Olli Saksela
Acta Dermato-Venereologica|June 21, 2003
Multinucleate cell angiohistiocytoma: a report of four cases in FinlandLiisa Väkevä, Olli Saksela, Arja-Leena Kariniemi
Acta Dermato-Venereologica|October 8, 2013
Melanoma on tattoos: two Finnish casesNicolas Kluger, Sari Koskenmies, Leila Jeskanen, et al.
Experimental Dermatology|March 3, 2005
FGF-2 blocks TGF-beta1-mediated suppression of Bcl-2 in normal melanocytesMaria von Willebrand, Klaus Köhler, Tuomo Alanko, et al.
The American Journal of Pathology|October 16, 2012
TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cellsMiao Yin, Johanna Soikkeli, Tiina Jahkola, et al.
Duodecim; Laaketieteellinen Aikakauskirja|August 5, 2015
[Diagnosis and treatment of actinic keratosis]Kirsi Isoherranen, Sari Koskenmies, Meri Overmark, et al.
The American Journal of Pathology|January 14, 2014
Osteopontin promotes the invasive growth of melanoma cells by activating integrin αvβ3 and down-regulating tetraspanin CD9Miao Yin, Johanna Soikkeli, Tiina Jahkola, et al.
The American Journal of Pathology|February 14, 2012
Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cellsPirjo Nummela, Johanna Lammi, Johanna Soikkeli, et al.
Molecular Oncology|February 14, 2020
Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel wallsJohanna Eriksson, Vadim Le Joncour, Tiina Jahkola, et al.
Virchows Archiv : an International Journal of Pathology|September 1, 2005
MMP-21 is upregulated at early stages of melanoma progression but disappears with more aggressive phenotypeTiina Kuivanen, Katja Ahokas, Susanna Virolainen, et al.
Pageof 2